4//SEC Filing
Vellanki Avanish 4
Accession 0000899243-22-011033
CIK 0001724979other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 3:23 PM ET
Size
7.7 KB
Accession
0000899243-22-011033
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2022-03-11$4.00/sh+14,468$57,872→ 2,837,009 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-11−14,468→ 31,832 totalExercise: $4.00Exp: 2030-11-12→ Common Stock (14,468 underlying)
Holdings
- 138,901(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This option represents a right to purchase a total of 46,300 shares of the Issuer's common stock, which vests in equal monthly installments through November 13, 2024, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
Rain Therapeutics Inc.
CIK 0001724979
Entity typeother
Related Parties
1- filerCIK 0001856682
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 3:23 PM ET
- Size
- 7.7 KB